SLC30A9

Across TCGA pan-cancer cohorts, SLC30A9 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated SLC30A9 data layer compared with 22 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher SLC30A9 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated SLC30A9 expression acts as an unfavorable survival marker, although some lineages such as COAD and GBM show a favorable association.

COAD, LSCC, and GBM are the cancer types where SLC30A9 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	All	1.000	0.918	.012	72	view →
LSCC	DFS	Quartile	II,III,IV	0.460	0.879	.005	15	view →
GBM	DFS	Quartile	All	0.879	0.657	.009	8	view →
HNSC	OS	Median	All	0.449	1.000	.023	6	view →
PDAC	DFS	Median	III,IV	0.940	0.488	.024	5	view →
CCRCC	DFS	Tertile	All	0.941	0.440	.010	4	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

SLC30A9–COAD (DFS)

Open the COAD breakdown →